You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 01 October 2024

Sec. Cardiovascular and Smooth Muscle Pharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1495716

Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)

  • 1. The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China

  • 2. The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

  • 3. Hefei First People’s Hospital, Huaihe Road, Hefei, Anhui, China

  • 4. Wenzhou Integrated Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China

  • 5. Nanyang Central Hospital, Nanyang, Henan, China

  • 6. Ningbo traditional Chinese Medicine Hospital, Ningbo, Zhejiang, China

  • 7. Taixing People’s Hospital, Taizhou, Jiangsu, China

  • 8. Xinghua People’s hospital, Taizhou, China

  • 9. Hunan Provincial People’s Hospital, Changsha, Hunan, China

  • 10. The First Hospital of Nanjing, Nanjing, Jiangsu, China

  • 11. The First Hospital of Jiaxing, Jiaxing, Zhejiang, China

  • 12. The First People’s Hospital of Kunshan, Suzhou, Jiangsu, China

  • 13. Chu Hsien-I Memorial Hospital of Tianjin Medical University, Tianjin, China

  • 14. Dalian Ruikaer Renal Disease Hospital, Dalian, Liaoning, China

  • 15. Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China

  • 16. Handan First Hospital, Handan, Heibei, China

  • 17. Linfen Central Hospital, Linfen, Shanxi, China

  • 18. Shanxi Provincial Hospital of Chinese Medicine, Shanxi, China

  • 19. Liaoning Health Industry Group Bensteel General Hospital, Benxi, Liaoning, China

  • 20. Nuclear Industry 416 Hospital, Chengdu, Sichuan, China

  • 21. Shiyan People’s Hospital, Shiyan, Hubei, China

  • 22. Qidong People’s Hospital Affiliated Qidong Hospital of Nantong University, Jiangsu, China

  • 23. Sandun District of Zhejiang Hospital, Zhejiang, China

  • 24. The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi, China

  • 25. Peking University People’s Hospital, Beijing, China

  • 26. Taian City Central Hospital, Tai’an, Shandong, China

  • 27. Jiangsu Province Official Hospital, Nanjing, Jiangsu, China

  • 28. Changshu No. 2 People’s Hospital, Suzhou, Jiangsu, China

  • 29. The Affiliated Hospital of Inner Mongolia Medical University, Hohho, Inner Mongolia, China

  • 30. Anshan Central Hospital, Anshan, Liaoning, China

  • 31. Tianjin People’s Hospital, Tianjin, China

  • 32. Tianjin TEDA Hospital, Tianjin, China

  • 33. Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China

  • 34. AstraZeneca Investment China Co., Medical Affairs, Shanghai, China

Article metrics

View details

1,7k

Views

929

Downloads

In the published article, there was an error in Affiliation 22. Instead of “Qidong People’s Hospital, The First Hospital of Tsinghua University, Beijing, China,” it should be “Qidong People’s Hospital Affiliated Qidong Hospital of Nantong University, Jiangsu, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

hyperkalemia, sodium zirconium cyclosilicate, safety, real-world clinical practice, Chinese population

Citation

Shen N, Zhang L, Yang J, Lin Y, Liu X, Cai X, Cao J, Zhu Q, Luo X, Wan X, Wu H, Ye J, Shan C, Xie H, Wu Y, Cao Y, Wang J, Yu X, Wang H, He J, Tian S, Wu F, Jiang X, Li L, Zuo L, Wang Z, Xing C, Yin X, Zhao J, Ma C, Long G, Li Q, Hu Y, Shi Y and Lin H-L (2024) Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study). Front. Pharmacol. 15:1495716. doi: 10.3389/fphar.2024.1495716

Received

13 September 2024

Accepted

16 September 2024

Published

01 October 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Hong-Li Lin,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics